tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
RedHill Biopharma Reports Strong First Half 2025 Results and Strategic Advances
PremiumCompany AnnouncementsRedHill Biopharma Reports Strong First Half 2025 Results and Strategic Advances
1M ago
RedHill Biopharma Secures Additional $1.8 Million in Legal Costs from New York Supreme Court
Premium
Company Announcements
RedHill Biopharma Secures Additional $1.8 Million in Legal Costs from New York Supreme Court
2M ago
RedHill awarded $1.82M in legal costs and expenses in action against Kukbo
Premium
The Fly
RedHill awarded $1.82M in legal costs and expenses in action against Kukbo
2M ago
RedHill Biopharma receives positive FDA feedback for RHB-204 in Crohn’s Disease
PremiumThe FlyRedHill Biopharma receives positive FDA feedback for RHB-204 in Crohn’s Disease
3M ago
RedHill Biopharma Initiates Phase 2 Prostate Cancer Study
Premium
Company Announcements
RedHill Biopharma Initiates Phase 2 Prostate Cancer Study
3M ago
RedHill initiates recruitment for expanded Phase 2 opaganib/darolutamide study
Premium
The Fly
RedHill initiates recruitment for expanded Phase 2 opaganib/darolutamide study
3M ago
RedHill Biopharma secures Kukbo asset freeze after $8.25M favorable court ruling
PremiumThe FlyRedHill Biopharma secures Kukbo asset freeze after $8.25M favorable court ruling
5M ago
RedHill Biopharma Postpones Annual Shareholders Meeting Due to Lack of Quorum
Premium
Company Announcements
RedHill Biopharma Postpones Annual Shareholders Meeting Due to Lack of Quorum
5M ago
RedHill Biopharma Launches H. Pylori Education Program at Gastroenterology Congress
Premium
Company Announcements
RedHill Biopharma Launches H. Pylori Education Program at Gastroenterology Congress
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100